One tumor was invasive lobular carcinoma that was hormone receptor-positive and human epidermal growth factor 2-positive, and the other was invasive ductal carcinoma that was hormone receptor-negative and human epidermal growth factor 2-positive. The gene discussed is NR4A1; the disease is invasive ductal breast carcinoma.